Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Barbey

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Pharmacology and Therapeutics|August 3, 1999
Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjectsJ T Barbey, M E Sale, R L Woosley, et al.
Clinical Pharmacology and Therapeutics|July 1, 1993
Immediate- versus controlled-release disopyramide: importance of saturable bindingR F Davies, L A Siddoway, L Shaw, et al.
Clinical Pharmacology and Therapeutics|March 10, 2001
Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongationD R Abernethy, J T Barbey, J Franc, et al.
British Journal of Clinical Pharmacology|April 12, 2001
Stereoselective halofantrine disposition and effect: concentration-related QTc prolongationD R Abernethy, D L Wesche, J T Barbey, et al.
American Journal of Rhinology|July 7, 1999
Cardiovascular safety of second-generation antihistaminesJ T Barbey, M Anderson, G Ciprandi, et al.
Clinical Pharmacology and Therapeutics|May 1, 1989
Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testingK T Murray, J T Barbey, H A Kopelman, et al.
Clinical Pharmacology and Therapeutics|March 10, 2001
Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmiaJ P Saul, B Ross, M S Schaffer, et al.
The Journal of Clinical Investigation|March 1, 1990
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockadeK T Murray, C Reilly, R P Koshakji, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Pharmacology and Therapeutics|August 3, 1999
Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjectsJ T Barbey, M E Sale, R L Woosley, et al.
Clinical Pharmacology and Therapeutics|July 1, 1993
Immediate- versus controlled-release disopyramide: importance of saturable bindingR F Davies, L A Siddoway, L Shaw, et al.
Clinical Pharmacology and Therapeutics|March 10, 2001
Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongationD R Abernethy, J T Barbey, J Franc, et al.
British Journal of Clinical Pharmacology|April 12, 2001
Stereoselective halofantrine disposition and effect: concentration-related QTc prolongationD R Abernethy, D L Wesche, J T Barbey, et al.
American Journal of Rhinology|July 7, 1999
Cardiovascular safety of second-generation antihistaminesJ T Barbey, M Anderson, G Ciprandi, et al.
Clinical Pharmacology and Therapeutics|May 1, 1989
Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testingK T Murray, J T Barbey, H A Kopelman, et al.
Clinical Pharmacology and Therapeutics|March 10, 2001
Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmiaJ P Saul, B Ross, M S Schaffer, et al.
The Journal of Clinical Investigation|March 1, 1990
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockadeK T Murray, C Reilly, R P Koshakji, et al.
Pageof 3